Table 6 Multivariable analysis to identify pretreatment clinical factors associated with posttreatment visual acuity.

From: Changes in corneal higher-order aberrations during treatment for infectious keratitis

 

B (95% CI)

β

P value

Pretreatment HOA (anterior, 6 mm)

0.020 (0.0043–0.036)

0.31

0.013

Pretreatment logMAR BSCVA

0.34 (0.21–0.48)

0.36

 < 0.0001

Age

0.0083 (0.0036–0.013)

0.35

0.0007

Adjusted R2

0.474

  
  1. One patient each with proliferative diabetic retinopathy, advanced glaucoma, and moderate-to-severe cataract were excluded from the analysis of visual acuity.
  2. BSCVA best spectacle-corrected visual acuity, HOA higher-order aberration, logMAR logarithm of the minimum angle of resolution, B partial regression coefficient, CI confidence interval, β  standardised partial regression coefficient, R2 coefficient of determination.